Chester Melvin Hedgepeth, III, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1999 | 492 | 0.330 |
Why?
|
| Acetanilides | 3 | 2010 | 169 | 0.220 |
Why?
|
| Xenopus Proteins | 3 | 1999 | 436 | 0.200 |
Why?
|
| Trans-Activators | 2 | 1999 | 2858 | 0.160 |
Why?
|
| Repressor Proteins | 2 | 1999 | 2987 | 0.150 |
Why?
|
| Lithium | 2 | 1999 | 600 | 0.150 |
Why?
|
| Mesencephalon | 1 | 1999 | 339 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1999 | 4534 | 0.130 |
Why?
|
| Glycogen Synthase Kinases | 3 | 1999 | 40 | 0.120 |
Why?
|
| Xenopus laevis | 1 | 1999 | 966 | 0.120 |
Why?
|
| Proteins | 2 | 1999 | 6008 | 0.110 |
Why?
|
| Piperazines | 3 | 2010 | 2546 | 0.110 |
Why?
|
| Zebrafish Proteins | 1 | 1999 | 1019 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 1999 | 414 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 3734 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 1997 | 1712 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 3611 | 0.070 |
Why?
|
| Acute Coronary Syndrome | 2 | 2010 | 2195 | 0.070 |
Why?
|
| Xenopus | 2 | 1999 | 710 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 1999 | 4417 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 2751 | 0.060 |
Why?
|
| Myocardial Infarction | 3 | 2010 | 11515 | 0.060 |
Why?
|
| Angina Pectoris | 1 | 2007 | 960 | 0.050 |
Why?
|
| beta Catenin | 2 | 1999 | 1048 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 2 | 1999 | 1337 | 0.050 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2010 | 1568 | 0.050 |
Why?
|
| Tachycardia, Ventricular | 1 | 2010 | 1309 | 0.050 |
Why?
|
| RGS Proteins | 1 | 1999 | 74 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 1999 | 182 | 0.040 |
Why?
|
| Molecular Mimicry | 1 | 1999 | 214 | 0.040 |
Why?
|
| Tinnitus | 1 | 2001 | 197 | 0.040 |
Why?
|
| Signal Transduction | 2 | 1999 | 23638 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2007 | 2258 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 1999 | 13452 | 0.040 |
Why?
|
| Wnt1 Protein | 1 | 1997 | 123 | 0.030 |
Why?
|
| Embryonic Induction | 1 | 1997 | 152 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2007 | 2139 | 0.030 |
Why?
|
| Cochlear Implantation | 1 | 2001 | 319 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 17647 | 0.030 |
Why?
|
| Inositol | 1 | 1997 | 216 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 1997 | 321 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 1999 | 724 | 0.030 |
Why?
|
| Larva | 1 | 1997 | 514 | 0.030 |
Why?
|
| Body Patterning | 1 | 1999 | 633 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 1170 | 0.030 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2001 | 783 | 0.030 |
Why?
|
| Placebos | 2 | 2010 | 1668 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1999 | 2184 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2007 | 5926 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1999 | 2525 | 0.030 |
Why?
|
| Oocytes | 1 | 1997 | 1168 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4586 | 0.020 |
Why?
|
| Thrombolytic Therapy | 2 | 2010 | 2058 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1999 | 2882 | 0.020 |
Why?
|
| Ventricular Premature Complexes | 1 | 2010 | 112 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1999 | 2910 | 0.020 |
Why?
|
| Protein Binding | 1 | 1999 | 9376 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2009 | 578 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1999 | 4948 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2010 | 6410 | 0.020 |
Why?
|
| Tachycardia | 1 | 2007 | 599 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2007 | 1266 | 0.010 |
Why?
|
| Models, Biological | 1 | 1999 | 9505 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 806 | 0.010 |
Why?
|
| Animals | 3 | 1999 | 169418 | 0.010 |
Why?
|
| Speech Reception Threshold Test | 1 | 2001 | 16 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 7246 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2001 | 1743 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2001 | 2286 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 12561 | 0.010 |
Why?
|
| Equipment Design | 1 | 2001 | 3530 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 74915 | 0.010 |
Why?
|
| Mice | 1 | 1999 | 82045 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 21552 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 30028 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 39430 | 0.000 |
Why?
|
| Middle Aged | 3 | 2009 | 223418 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2009 | 24311 | 0.000 |
Why?
|
| Aged | 2 | 2009 | 171520 | 0.000 |
Why?
|
| Male | 3 | 2009 | 364781 | 0.000 |
Why?
|
| Female | 3 | 2009 | 396943 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 15965 | 0.000 |
Why?
|
| Humans | 4 | 2010 | 768451 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2009 | 65409 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2001 | 54914 | 0.000 |
Why?
|
| Adult | 1 | 2001 | 223542 | 0.000 |
Why?
|